Sanofi is shelling out $1.15 billion to acquire Vicebio, a startup with a pipeline of respiratory vaccine candidates and a platform technology that will support the pharmaceutical giant’s ambitions to ...
Among hospitalized children and teens, respiratory syncytial virus (RSV) mostly affects younger, otherwise healthy infants, while the lesser-known human metapneumovirus (HMPV) tends to affect older ...
A respiratory virus has been spreading in several states that isn’t the flu or a cold. The Centers for Disease Control and Prevention said the number of cases of human metapneumovirus has been growing ...
A deluge of disinformation about a flu-like virus called HMPV is stoking anti-China sentiment across Asia and spurring unfounded concerns of renewed lockdowns, despite experts dismissing comparisons ...
A relatively unknown respiratory virus is spreading throughout the nation. Infections of human metapneumovirus, or HMPV, have been climbing in the U.S. since fall 2025. The Center for Disease Control ...
Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially on Signal at drewqjoseph.71. LONDON — Sanofi on Tuesday said it ...
TRIAL ON 55 CHARGES TIED TO THE SHOOTING. WELL, IT’S BEEN A ROUGH COLD AND FLU SEASON, AND A LESSER KNOWN VIRUS IS NOW HITTING SCHOOLS AND OFFICES QUITE HARD. IT’S CALLED METAPNEUMOVIRUS OR HMPV, AND ...
A little-known virus that causes nasty flu-like symptoms is spreading in California — and it doesn’t have a vaccine. Cases of human metapneumovirus (HMPV) have been steadily rising since winter began, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results